| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,168 |
18,096 |
$914K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,522 |
8,461 |
$182K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
900 |
892 |
$127K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
12,029 |
7,522 |
$122K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
8,985 |
8,883 |
$84K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,056 |
1,021 |
$82K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
751 |
751 |
$45K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,358 |
1,342 |
$42K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
662 |
662 |
$38K |
| 96127 |
|
2,670 |
2,654 |
$30K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
504 |
502 |
$26K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
313 |
310 |
$25K |
| 99188 |
|
843 |
839 |
$23K |
| 99173 |
|
1,008 |
1,003 |
$16K |
| 90461 |
|
859 |
856 |
$14K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
142 |
140 |
$9K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
113 |
112 |
$9K |
| 92552 |
|
332 |
332 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
432 |
431 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
136 |
134 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
176 |
173 |
$4K |
| 0071A |
|
80 |
79 |
$4K |
| 99051 |
|
187 |
181 |
$3K |
| 0072A |
|
42 |
42 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
129 |
124 |
$2K |
| 92551 |
|
158 |
158 |
$2K |
| 85018 |
|
276 |
276 |
$582.49 |
| 90686 |
|
4,077 |
4,062 |
$564.65 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
37 |
37 |
$471.52 |
| 99177 |
|
155 |
155 |
$407.56 |
| ATP03 |
|
50 |
50 |
$342.50 |
| 96160 |
|
254 |
251 |
$2.14 |
| 91307 |
|
136 |
134 |
$0.00 |
| 90680 |
|
15 |
15 |
$0.00 |
| 90698 |
|
12 |
12 |
$0.00 |
| 90651 |
|
14 |
14 |
$0.00 |
| 90670 |
|
43 |
43 |
$0.00 |